NHMRC Clinical Trials Centre

What NHMRC Clinical Trials Centre does

The Sydney Clinical Trials Centre (operating as NHMRC Clinical Trials Centre) is a non-profit clinical research centre within the University of Sydney's Faculty of Medicine and Health, founded in 1988 and headquartered in Camperdown, NSW, Australia. It delivers end-to-end clinical trial services spanning trial design, project management, custom data systems development, quality and safety management, biostatistics, and health economics, underpinned by methodological expertise and advanced analytics capability. Its clients include global pharmaceutical, biotechnology, and medical device industry leaders, government health agencies, hospital networks and health systems, academic research collaborators, and consumer/patient representatives, served through direct partnership engagements across more than 40 countries.

The centre operates on a professional services revenue model, generating income through negotiated industry contracts, government agreements, and research grants; pricing is not publicly disclosed. Its go-to-market is enterprise field sales in nature, conducted via formal partnership enquiries and research collaboration agreements with sponsors seeking regulatory-ready evidence. In 2025, the centre ran 121 trials, published 355 peer-reviewed publications, and recorded a field weighted citation index of 3.25, indicating research output materially above the global baseline. Operational scale sits at 145 employees across two physical sites on the Royal Prince Alfred Hospital campus and one mailing address, with no disclosed subsidiaries, funding rounds, M&A activity, or leadership transitions in the available data.

Name

NHMRC Clinical Trials Centre

Legal name

Sydney Clinical Trials Centre

Website

https://ctc.usyd.edu.au

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

The Sydney Clinical Trials Centre is a University of Sydney-affiliated non-profit research centre that designs, delivers, and analyses clinical trials for global pharmaceutical, biotech, and medical device sponsors, government agencies, and health systems across more than 40 countries.

Ownership category

akta.pro rank

Product category

Clinical Trials Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE), Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL)

Keywords

• Clinical trials research
• Trial design services
• Biostatistics services
• Health economics research
• Regulatory evidence generation

Headquarters

HQ city

Camperdown

HQ country

Australia

HQ region

Oceania

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Research Partnerships and Contracts: The centre operates as a research entity within the University of Sydney, generating revenue through industry partnerships, government contracts, and research grants for conducting clinical trials and related research.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

The NHMRC Clinical Trials Centre (legally Sydney Clinical Trials Centre) is a university-affiliated clinical research organisation that delivers end-to-end clinical trial services across the full trial lifecycle. Its offerings span trial design, project management, data systems development, quality and safety management, biostatistics, and health economics, underpinned by methodological expertise and advanced analytics to generate regulatory-ready evidence.

Product overview

The Sydney Clinical Trials Centre is a clinical research services provider that offers an integrated suite of trial-related services rather than a software product platform. Its offerings span the full trial lifecycle including trial design, project management, data systems development, quality and safety management, biostatistics, and health economics. These are service offerings delivered by expert teams rather than distinct branded software products or modules.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trials Design and Delivery
• Biostatistics and Health Economics Analysis
• Clinical Trial Data Systems Development

Quantifiable outcome

• 121 trials conducted in 2025
• +3 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• Berry Consultants: Specialist biostatistics and adaptive trial design consultancy supporting Phase I–III trials with advanced methodology. Comparable to the centre's advanced analytics / biostatistics moat, though narrower in scope (no site operations).
• Duke Clinical Research Institute: US academic clinical research institute embedded within Duke University, conducting large-scale, multi-centre trials including Phase I–IV and pragmatic clinical studies. Closest analogue in scale, university-affiliation, and end-to-end trial design / biostatistics / health economics expertise.
• Nuffield Department of Population Health (Oxford): University of Oxford division running large-scale randomised trials, including the CTSU-led cardiovascular and cancer mega-trials. Comparable in academic independence, scale of trial output, and integrated trial design + biostatistics capability.
• Cancer Research UK Clinical Trials Unit: University-of-Birmingham affiliated, charity-funded clinical trials unit running investigator-led and industry-sponsored oncological trials. Comparable academic-CRO model with parallel emphasis on methodology, statistics, and health economics.
• MRC Clinical Trials Unit at UCL: UK university-based CTU delivering randomised trials from design through analysis with strong methodology, statistics, and health economics capacity. Direct academic-CTU counterpart serving government and industry sponsors across multiple indications.
• George Clinical: Asia-Pacific headquartered, academic-grade contract research organisation with end-to-end clinical trial services across biostatistics, project management, and site operations. Highly comparable as a regionally anchored, science-led CRO competing for similar pharma and government-sponsored trials.

Broad incumbents

• IQVIA: World's largest commercial CRO with deep technology platforms (eCOA, EDC, data analytics) and full Phase I–IV execution across >100 countries. Competes for the same global pharma and biotech RFPs at scale, representing the upper bound of incumbent capability.
• Parexel International: Global commercial CRO with a legacy in biostatistics, data management, and full-service trial execution for pharma and biotech. The closest legacy CRO analogue to the centre's biostatistics-and-trial-design orientation.
• PPD (Thermo Fisher Scientific): Full-service commercial CRO now integrated into Thermo Fisher Scientific, offering end-to-end trial design, biostatistics, and site management worldwide. Comparable end-to-end stack and customer base, but commercially scaled.

Regional players

• Clinical Trials Service Unit, University of Auckland: New Zealand-based academic clinical trials unit focused on cardiovascular and metabolic mega-trials, embedded in the University of Auckland. Geographic and academic-CRO model peer in the same Australasian region.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks4 records

Key highlights7 records

Customer concentration

• Xx.com/TrialsCentre
• LinkedInlinkedin.com/company/nhmrc-clinical-trials-centre

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NHMRC Clinical Trials Centre